
Orna Therapeutics Appoints Joseph Bolen, Ph.D., as Chief Executive Officer
-- Dr. Bolen has an established track record advancing disruptive medicines from the clinic through approval -- WATERTOWN, Mass., March 31, 2025 /PRNewswire/ -- Orna Therapeutics, a biotechnology company dedicated to engineering immune cells in …